Studies

• Science behind Fevipiprant
• Fevi vs Seti
• Binding Power and Affinity for the CRTH2 Receptor
• How PGD2 is responsible for hairloss
• Diagram

Media

• Guardian - Asthma drug 'gamechanger' could revolutionise treatment
• PharmaTimes - Novartis' fevipiprant hailed a "game-changer" in asthma treatment

Side Effects & Safety

• Similar to Seti which is mild and rare
• Practically no chance of sexual sides because it doesn't mess with hormones or PGD2 Production See here
• Fevipiprant is in phase 3 trials all over the world. You do not usually reach Phase 3 unless safety is sufficiently established and that many trials indicates it would be safe. And they already looking at Asthma mild all the way to severe, atopic dermatitis and rhinitis.

Quelle: https://www.hairlosstalk.com/interact/threads/qaw039-fevipiprant-interest-thread-oral-once-a-day-pgd2-antagonist.103292/